INNERSE BIOTECHNOLOGY
Molecular formula：C44H87NO5
Molecular weight：710.17
Property data：
| Boiling Point | 725.8±50.0 ℃(Predicted) |
| Density | 0.925±0.06 g/cm3(Predicted) |
| pKa | 14.67±0.10(Predicted) |
Related categories: COVID-19 vaccine excipients; cationic lipids; LNPs delivery system excipients
Usage: SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles.1 Administration of luciferase mRNA in SM-102-containing lipid nanoparticles induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines.
Specifications:95% HPLC (ELSD)
Molecular formula：C44H87NO5
Molecular weight：710.17
Property data：
| Boiling Point | 725.8±50.0 ℃(Predicted) |
| Density | 0.925±0.06 g/cm3(Predicted) |
| pKa | 14.67±0.10(Predicted) |
Related categories: COVID-19 vaccine excipients; cationic lipids; LNPs delivery system excipients
Usage: SM-102 is an ionizable amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles.1 Administration of luciferase mRNA in SM-102-containing lipid nanoparticles induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of lipid nanoparticles for delivery of mRNA-based vaccines.
